Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral

Background: Loxoscelism is an important public health problem in Chile and South America, due to the higher rate of cutaneous-visceral involvement. The diagnosis of loxoscelism is mostly clinical without established diagnostic criteria. There is little evidence to support any treatment used in this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Droppelmann,Katherine, Majluf-Cáceres,Paula, Sabatini-Ugarte,Natalia, Valle,Elizabeth, Herrera,Hernán, Acuña,David
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2021
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500682
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872021000500682
record_format dspace
spelling oai:scielo:S0034-988720210005006822021-11-03Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceralDroppelmann,KatherineMajluf-Cáceres,PaulaSabatini-Ugarte,NataliaValle,ElizabethHerrera,HernánAcuña,David Brown Recluse Spider Spider Bites Spider Venoms Background: Loxoscelism is an important public health problem in Chile and South America, due to the higher rate of cutaneous-visceral involvement. The diagnosis of loxoscelism is mostly clinical without established diagnostic criteria. There is little evidence to support any treatment used in this condition. Aim: To characterize the clinical features and epidemiology of loxoscelism among patients consulting at the Emergency and Dermatology Services of a clinical hospital between 2013 and 2017. Material and Methods: Review of medical records of patients registered in the electronic clinical record system with a confirmed diagnosis of loxoscelism. Epidemiological, clinical, laboratory tests and treatment variables were analyzed. Results: We reviewed data from 200 patients. Ninety-four percent presented cutaneous loxoscelism and 5.5% cutaneous-visceral loxoscelism. Systemic symptoms were present in 73% of patients with cutaneous-visceral loxoscelism. Patients who developed systemic symptoms had an 18 times higher risk of developing cutaneous-visceral loxoscelism. Laboratory abnormalities were more common in patients with cutaneous-visceral loxoscelism. Not all patients with hematuria had cutaneous-visceral loxoscelism. Most patients required analgesia. Anti-loxosceles serum was not used in any patient. Conclusions: Many questions remain to be answered regarding the diagnosis and treatment of the disease. Studies are required to validate diagnostic criteria for loxoscelism, predictors for visceral involvement and response to treatment.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.149 n.5 20212021-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500682es10.4067/s0034-98872021000500682
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Brown Recluse Spider
Spider Bites
Spider Venoms
spellingShingle Brown Recluse Spider
Spider Bites
Spider Venoms
Droppelmann,Katherine
Majluf-Cáceres,Paula
Sabatini-Ugarte,Natalia
Valle,Elizabeth
Herrera,Hernán
Acuña,David
Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral
description Background: Loxoscelism is an important public health problem in Chile and South America, due to the higher rate of cutaneous-visceral involvement. The diagnosis of loxoscelism is mostly clinical without established diagnostic criteria. There is little evidence to support any treatment used in this condition. Aim: To characterize the clinical features and epidemiology of loxoscelism among patients consulting at the Emergency and Dermatology Services of a clinical hospital between 2013 and 2017. Material and Methods: Review of medical records of patients registered in the electronic clinical record system with a confirmed diagnosis of loxoscelism. Epidemiological, clinical, laboratory tests and treatment variables were analyzed. Results: We reviewed data from 200 patients. Ninety-four percent presented cutaneous loxoscelism and 5.5% cutaneous-visceral loxoscelism. Systemic symptoms were present in 73% of patients with cutaneous-visceral loxoscelism. Patients who developed systemic symptoms had an 18 times higher risk of developing cutaneous-visceral loxoscelism. Laboratory abnormalities were more common in patients with cutaneous-visceral loxoscelism. Not all patients with hematuria had cutaneous-visceral loxoscelism. Most patients required analgesia. Anti-loxosceles serum was not used in any patient. Conclusions: Many questions remain to be answered regarding the diagnosis and treatment of the disease. Studies are required to validate diagnostic criteria for loxoscelism, predictors for visceral involvement and response to treatment.
author Droppelmann,Katherine
Majluf-Cáceres,Paula
Sabatini-Ugarte,Natalia
Valle,Elizabeth
Herrera,Hernán
Acuña,David
author_facet Droppelmann,Katherine
Majluf-Cáceres,Paula
Sabatini-Ugarte,Natalia
Valle,Elizabeth
Herrera,Hernán
Acuña,David
author_sort Droppelmann,Katherine
title Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral
title_short Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral
title_full Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral
title_fullStr Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral
title_full_unstemmed Caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral
title_sort caracterización clínica y epidemiológica de 200 pacientes con loxoscelismo cutáneo y cutáneo visceral
publisher Sociedad Médica de Santiago
publishDate 2021
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872021000500682
work_keys_str_mv AT droppelmannkatherine caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral
AT majlufcacerespaula caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral
AT sabatiniugartenatalia caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral
AT valleelizabeth caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral
AT herrerahernan caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral
AT acunadavid caracterizacionclinicayepidemiologicade200pacientesconloxoscelismocutaneoycutaneovisceral
_version_ 1718437202728321024